Product Details
Actemra 162 mg**
Tocilizumab162 mg/0.9 mL
Solution for injection
ROA
Subcutaneous
Applicant Name
Roche Products Limited
NRN
A6-100070
Status
Active
Composition
Each single-dose prefilled syringe contains: Tocilizumab 162 mg in 0.9 mL solution. Tocilizumab is a humanized IgG1 monoclonal antibody against the human interleukin-6 (IL-6) receptor produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology
ATC Code
L04AC07
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
0.9 mL x 4’s (in pre-filled syringed)
Product Description
Solution for injection in single-dose pre-filled syringe for SC injection. A preservative-free, sterile clear, colourless to pale yellow solution
Manufacturer Name
Vetter Pharma-Fertigung GmbH & Co. KG
Manufacturer Country
GERMANY
Approval Date
2023-02-19
Expiry Date
2028-02-18